Literature DB >> 26921528

The use of two different MLPA kits in 22q11.2 deletion syndrome.

L J M Evers1, J J M Engelen2, L M H Houben2, L M G Curfs3, T A M J van Amelsvoort4.   

Abstract

22q11.2 deletion syndrome (22q11DS) is one of the most common recurrent copy-number variant disorder, caused by a microdeletion in chromosome band 22q11.2 and occurring with a population prevalence of 1 in 2000. Until today there has been no evidence that the size of the deletion has an influence on the clinical phenotype. Most studies report that 22q11DS is associated with mild or borderline intellectual disability. There are a limited number of reports on 22q11DS subjects with moderate or severe intellectual disability. In this study we describe 63 adult patients with 22q11DS, including 22q11DS patients functioning at a moderate to severe intellectual disabled level. Deletion size was established with an experimental Multiplex ligation-dependent probe amplification (MLPA) mixture (P324) in addition to the commonly used MLPA kit (P250). We compared deletion size with intellectual functioning and presence of psychotic symptoms during life. The use of the experimental MLPA kit gives extra information on deletion size, only when combined with the common MLPA kit. We were able to detect eleven atypical deletions and in two cases the deletion size was shorter than all other "typical ones". We conclude that the use of the experimental kit P324 gives extra information about the deletion size, but only when used together with the standard P250 kit. We did not found any relation of deletion size with intelligence or presence of psychosis.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  22q11 deletion syndrome; Cognitive deterioration; Deletion size; Intelligence; MLPA; Psychopathology

Mesh:

Substances:

Year:  2016        PMID: 26921528      PMCID: PMC4820537          DOI: 10.1016/j.ejmg.2016.02.009

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  34 in total

1.  On cognitive variability in velocardiofacial syndrome: profound mental retardation and autism.

Authors:  C Kozma
Journal:  Am J Med Genet       Date:  1998-05-08

2.  PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome.

Authors:  Mariken B de Koning; Esther D A van Duin; Erik Boot; Oswald J N Bloemen; Jaap A Bakker; Kathryn M Abel; Thérèse A M J van Amelsvoort
Journal:  Psychopharmacology (Berl)       Date:  2015-06-12       Impact factor: 4.530

3.  Cerebellar hypoplasia in a patient with velo-cardio-facial syndrome.

Authors:  K Devriendt; M N Thienen; A Swillen; J P Fryns
Journal:  Dev Med Child Neurol       Date:  1996-10       Impact factor: 5.449

4.  Molecular characterization of 22q11 deletion in a three-generation family with maternal transmission.

Authors:  Maria R Iascone; Simona Vittorini; Monica Sacchelli; Isabella Spadoni; Paolo Simi; Sandra Giusti
Journal:  Am J Med Genet       Date:  2002-04-01

5.  Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes.

Authors:  Petya D Radoeva; Ioana L Coman; Cynthia A Salazar; Karen L Gentile; Anne Marie Higgins; Frank A Middleton; Kevin M Antshel; Wanda Fremont; Robert J Shprintzen; Bernice E Morrow; Wendy R Kates
Journal:  Psychiatr Genet       Date:  2014-12       Impact factor: 2.458

6.  Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome.

Authors:  Therese van Amelsvoort; Jayne Henry; Robin Morris; Michael Owen; Don Linszen; Kieran Murphy; Declan Murphy
Journal:  Schizophr Res       Date:  2004-10-01       Impact factor: 4.939

7.  Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes.

Authors:  Omer Zarchi; Miri Carmel; Chen Avni; Josef Attias; Amos Frisch; Elena Michaelovsky; Miriam Patya; Tamar Green; Ronnie Weinberger; Abraham Weizman; Doron Gothelf
Journal:  J Psychiatr Res       Date:  2013-08-01       Impact factor: 4.791

Review 8.  Velo-cardio-facial syndrome: 30 Years of study.

Authors:  Robert J Shprintzen
Journal:  Dev Disabil Res Rev       Date:  2008

9.  Role of TBX1 in human del22q11.2 syndrome.

Authors:  Hisato Yagi; Yoshiyuki Furutani; Hiromichi Hamada; Takashi Sasaki; Shuichi Asakawa; Shinsei Minoshima; Fukiko Ichida; Kunitaka Joo; Misa Kimura; Shin-ichiro Imamura; Naoyuki Kamatani; Kazuo Momma; Atsuyoshi Takao; Makoto Nakazawa; Nobuyoshi Shimizu; Rumiko Matsuoka
Journal:  Lancet       Date:  2003-10-25       Impact factor: 79.321

10.  Mouse Models of 22q11.2-Associated Autism Spectrum Disorder.

Authors:  Noboru Hiroi; Takeshi Hiramoto; Kathryn M Harper; Go Suzuki; Shuken Boku
Journal:  Autism Open Access       Date:  2012
View more
  2 in total

1.  Deletion size analysis of 1680 22q11.2DS subjects identifies a new recombination hotspot on chromosome 22q11.2.

Authors:  Tingwei Guo; Alexander Diacou; Hiroko Nomaru; Donna M McDonald-McGinn; Matthew Hestand; Wolfram Demaerel; Liangtian Zhang; Yingjie Zhao; Francisco Ujueta; Jidong Shan; Cristina Montagna; Deyou Zheng; Terrence B Crowley; Leila Kushan-Wells; Carrie E Bearden; Wendy R Kates; Doron Gothelf; Maude Schneider; Stephan Eliez; Jeroen Breckpot; Ann Swillen; Jacob Vorstman; Elaine Zackai; Felipe Benavides Gonzalez; Gabriela M Repetto; Beverly S Emanuel; Anne S Bassett; Joris R Vermeesch; Christian R Marshall; Bernice E Morrow
Journal:  Hum Mol Genet       Date:  2018-04-01       Impact factor: 6.150

2.  Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjects.

Authors:  Yingjie Zhao; Tingwei Guo; Ania Fiksinski; Elemi Breetvelt; Donna M McDonald-McGinn; Terrence B Crowley; Alexander Diacou; Maude Schneider; Stephan Eliez; Ann Swillen; Jeroen Breckpot; Joris Vermeesch; Eva W C Chow; Doron Gothelf; Sasja Duijff; Rens Evers; Thérèse A van Amelsvoort; Marianne van den Bree; Michael Owen; Maria Niarchou; Carrie E Bearden; Claudia Ornstein; Maria Pontillo; Antonino Buzzanca; Stefano Vicari; Marco Armando; Kieran C Murphy; Clodagh Murphy; Sixto Garcia-Minaur; Nicole Philip; Linda Campbell; Jaume Morey-Cañellas; Jasna Raventos; Jordi Rosell; Damian Heine-Suner; Robert J Shprintzen; Raquel E Gur; Elaine Zackai; Beverly S Emanuel; Tao Wang; Wendy R Kates; Anne S Bassett; Jacob A S Vorstman; Bernice E Morrow
Journal:  Am J Med Genet A       Date:  2018-10-05       Impact factor: 2.802

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.